What Is Emface?

Emface uses two energies at once:

1. Synchronized radiofrequency (RF). FDA's summary for the BTL-785-7 applicator describes radiofrequency heating as part of the hands-free treatment, with an effective treatment temperature range of 40–45 °C in the device comparison table. BTL describes the RF as heating dermal tissue to support collagen and elastin remodeling. That is manufacturer mechanism language, not an FDA outcome claim.
2. HIFES® (high-intensity facial electrical stimulation). BTL's branded term for the electrical muscle-stimulation half of the treatment. FDA describes the BTL-785-7 as integrating RF heating with muscle stimulation that results in an induced muscle workout. Manufacturer materials say HIFES selectively stimulates facial elevator muscles (for example, forehead and cheek elevators) with many contractions per session.

Applicators are single-use adhesive electrodes placed on treatment areas such as the forehead and cheeks (and, when used, the submentum). Jewelry and hair in the field are typically cleared before treatment, per clinical-study protocol language in the FDA summary.

FDA "clearance" through the 510(k) pathway means the agency found the device substantially equivalent to a legally marketed device for the listed uses. It is not the same as approving a drug.

Also on manufacturer labeling (bodybybtl.com Important Information, accessed Nov. 6, 2026): EMFACE® Eye / Submentum aesthetic language, and EMFACE® Functional TMJ indications (TMJ dysfunction and associated pain, muscle spasm symptom relief, muscle re-education, blood flow, mandibular range of motion). Cite those as manufacturer-stated FDA-cleared uses until a separate TMJ 510(k) PDF is pulled for the page.

Not Emface: InMode's separately cleared "EmFace Device" (K191855, 2019) is a different product. This guide covers BTL EMFACE® only.

Both clearances above were supported by company clinical investigations summarized in the 510(k)s. They were single-arm and open-label (no sham or active comparator in the summaries), with about three months of follow-up:

• Facial wrinkles (K222556): 42 people completed four treatments. Blinded evaluators documented an average 1.44-point FWES improvement at three months. No adverse events were recorded in the investigation. All participants reported being satisfied or very satisfied, and all found the procedure comfortable.
• Submental lax tissue (K233604): 56 people completed four treatments. Independent reviewers scored GAIS improvement in 91% (51/56). 82% (46/56) showed a ≥20 mm² reduction in the measured submental area at three months. Mean pain was 0.46 on a 0–10 scale. No adverse events were recorded.

These studies show measurable change versus baseline in selected patients. They do not prove Emface outperforms fillers, neuromodulators, Ultherapy, Sofwave or surgery, and they do not show how long results last beyond the follow-up window.

Peer-reviewed papers on simultaneous synchronized RF and HIFES (for example, Goldberg and Lal, Journal of Cosmetic Dermatology, 2024, PMID 38468421; Kinney and Boyd, Journal of Cosmetic Dermatology, 2024, PMID 38235951) report histologic or soft-tissue remodeling findings in small cohorts. Treat them as early evidence, not guarantees.

According to BTL's patient-facing materials:

• a session lasts about 20 minutes;
• you remain clothed for the face; adhesive applicators are placed on the treatment areas;
• sensation is typically described as warmth plus involuntary muscle contractions (company FAQ: similar to a facial massage / gentle contractions);
• the company's standard aesthetic course is four sessions, often spaced about a week apart — your clinician may adjust the plan;
• anesthesia is generally not required in the FDA facial study protocol language.

Ask who operates the device in that practice and who supervises the treatment.

• Downtime: BTL states Emface requires no downtime and that patients can resume daily activities right after treatment.
• Side effects (manufacturer Important Information): possible temporary damage to natural skin, including crust, blister, and burn. You should feel comfortable heat during treatment, not an unpleasant burning or pain sensation — stop and tell the operator if you do.
• FDA study safety notes: the facial and submental investigations summarized above reported no adverse events in those enrolled cohorts; that does not mean side effects never occur in practice.

Often discussed for: people seeking a needle-free option for temporary improvement in facial wrinkles (forehead/cheeks) or the appearance of submental lax tissue, who understand results are typically modest and maintenance-dependent.

Emface does not replace: volume restoration with fillers, dynamic-line treatment with neuromodulators, or surgical lifting. It also does not treat every facial concern.

Manufacturer Important Information cautions include: do not apply treatment over hair or scar tissue, or if you have electronic or metal implants. As with any medical device procedure, review your full health history — including pregnancy, active skin infection or inflammation in the area, and implanted devices — with a physician before treatment.

High-level differences only — this page does not rank treatments:

None of these replaces a facelift or neck lift when skin laxity or structural aging needs surgery. For the broader category, see What Is Skin Tightening?.

See a board-certified dermatologist or plastic surgeon if you are considering Emface, especially if you have facial implants, a pacemaker or other electronic implant, metal in the treatment area, active skin disease, or you are unsure whether wrinkles, volume loss or muscle-driven lines are your main concern. A consultation should map your goal to a cleared use — or explain when another option fits better.

Featured doctors: Haute MD Network members include Dr. Lisa Airan, a board-certified cosmetic dermatologist in Manhattan whose practice includes skin-tightening technologies such as Thermage and EmFace, and Dr. Oliver Chang, a double board-certified plastic surgeon in Miami whose practice includes facial rejuvenation and injectable treatments. Browse Dermatology and Plastic Surgery in Find a Doctor. Listed doctors are paid members of the Haute MD Network. Editorial selection, not a ranking.

Related

• What Is Skin Tightening?
• What Is Sofwave?
• What Is Ultherapy?
• Sofwave vs. Ultherapy
• What Is RF Microneedling?
• EmFace in Fort Collins: Xanadu Med Spa's Non-Surgical Lift (partner feature — not this clinical guide)

Browse Haute MD physicians in Find a Doctor, including Dermatology and Plastic Surgery.

• FDA 510(k) summary, BTL Industries, K222556 (BTL-785X; decision May 31, 2023): PDF; database record (accessed Nov. 6, 2026)
• FDA 510(k) summary, BTL Industries, K233604 (BTL-785S; decision March 28, 2024): PDF; database record (accessed Nov. 6, 2026)
• BTL, EMFACE® product page — mechanism, protocol, downtime FAQ, Important Information / labeling language (accessed Nov. 6, 2026)
• BTL Aesthetics, EMFACE launch press release (Sept. 19, 2022; manufacturer context only — headline percentages not used as page facts)
• Goldberg DJ, Lal K. Treatment with synchronized radiofrequency and facial muscle stimulation: Histologic analysis of human skin for changes in collagen and elastin fibers. J Cosmet Dermatol. 2024. PMID 38468421; doi:10.1111/jocd.16273
• Kinney BM, Boyd CM. Remodeling of facial soft tissue induced by simultaneous application of HIFES and synchronized radiofrequency provides nonsurgical lift of facial soft tissues. J Cosmet Dermatol. 2024. PMID 38235951; doi:10.1111/jocd.16165
• openFDA / FDA 510(k) database note: InMode "EmFace Device" K191855 is a separate clearance — not cited as BTL Emface (checked Nov. 6, 2026)

This guide is for general information and isn't medical advice. Talk with a board-certified physician about whether a treatment is right for you.